Study of Efficacy of Sublingual Immunotherapy in Cases Asthma & Allergic Rhinitis in India

D. Pandey (Kolkata (West Bengal), India)

Source: International Congress 2017 – Evolution or revolution in the treatment of asthma and allergies
Session: Evolution or revolution in the treatment of asthma and allergies
Session type: Thematic Poster
Number: 4035
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
D. Pandey (Kolkata (West Bengal), India). Study of Efficacy of Sublingual Immunotherapy in Cases Asthma & Allergic Rhinitis in India. 4035

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Safety and Efficacy of Omalizumab in Elderly Patients with Uncontrolled Allergic Asthma.
Source: International Congress 2017 – Evolution or revolution in the treatment of asthma and allergies
Year: 2017


Effects of MACVIA-ARIA Sentinel Network for Allergic Rhinitis (MASK-Air) Mobile Phone Application on Asthma Control in Patients with Asthma
Source: Virtual Congress 2020 – Management of allergy, asthma and COPD
Year: 2020


Tolerance of ultra-rush immunotherapy in children
Source: International Congress 2015 – Immune aspects of asthma and other airway diseases
Year: 2015

Dupilumab Effect on Lung Function in Patients With Uncontrolled, Moderate-to-Severe Asthma With an Allergic Phenotype
Source: International Congress 2019 – Understanding, monitoring and targeting severe asthma
Year: 2019


Cost Effectiveness Of Bronchial Thermoplasty For Treatment Of Severe Asthma Patients In Scotland
Source: International Congress 2017 – Does economisation of medicine transfer into benefits for patients?
Year: 2017

Immunogenicity of Mepolizumab in Patients with Severe Eosinophilic Asthma: Experience from the Clinical Development Program
Source: International Congress 2018 – Novel immunology-based therapies in asthma and COPD
Year: 2018



Allergic rhinitis does it have an impact on controller asthma therapy choice
Source: International Congress 2014 – Paediatric asthma: pharmacological and non-pharmacological management
Year: 2014


Ultra-rush sublingual immunotherapy: Safety of use for patients with various allergic manifestations
Source: International Congress 2015 – Modulating the immune system in COPD and asthma
Year: 2015


Effectiveness of Nebulized Budesonide in Iranian Patients with Asthma Attack
Source: Virtual Congress 2020 – Advances in asthma treatment
Year: 2020


Clinically Meaningful Improvement in Total Rhinoconjunctivitis Score with Olopatadine/mometasone Combination Nasal Spray in Patients with Seasonal Allergic Rhinitis: A Pooled Analysis
Source: Virtual Congress 2021 – Asthma clinical trials and real-life studies
Year: 2021


The Impact of Current Smoking on Severe Asthma in the Wessex Severe Asthma Cohort
Source: International Congress 2019 – Clinical aspects of airway diseases
Year: 2019

Evaluation of Asthma control and oral corticosteroids in Severe Asthma
Source: Virtual Congress 2021 – Advances in asthma treatment
Year: 2021

Allergy Testing in Asthmatics and Severe Asthmatics in Belgium : Role of Comorbidities
Source: Virtual Congress 2020 – Asthma management: role of biomarkers and comorbidities
Year: 2020


Dupilumab Efficacy in Type 2 Inflammatory Asthma: Liberty Asthma QUEST Study
Source: International Congress 2019 – Precision meets immunology in treatment of airway diseases
Year: 2019



Sensitization to three mites in Cuban children with allergic respiratory diseases
Source: International Congress 2014 – Paediatric asthma: epidemiology and risk factors
Year: 2014

Asthma in the elderly: Clinical findings
Source: Annual Congress 2013 –Asthma
Year: 2013


Assessment of Efficacy Omalizumab Retreatment in Patients With Severe Asthma
Source: International Congress 2018 – Role of IgE and interleukin (IL)-5 in Th2-cell signatures
Year: 2018

Real-world Omalizumab and Mepolizumab treated Difficult Asthma Phenotypes and their Clinical Outcomes
Source: Virtual Congress 2021 – Advances in asthma treatment: monoclonal antibodies
Year: 2021

Allergen analysis of 2778 patients with allergic diseases in China
Source: International Congress 2016 – Laboratory tests and cell biology in allergy and immunology
Year: 2016


Tolerability and adherence to sublingual immunotherapy with mite vaccines with different schedule in asthmatic children
Source: International Congress 2014 – More paediatric asthma
Year: 2014